Oppenheimer Reiterates Outperform Rating, $6 Price Target on CASI Pharmaceuticals (CASI) Following Company's Q1 Update

Go back to Oppenheimer Reiterates Outperform Rating, $6 Price Target on CASI Pharmaceuticals (CASI) Following Company's Q1 Update
Careside, Inc. (NASDAQ: CASI) Delayed: 0.21 --0 (-0%)
Previous Close $0.21    52 Week High $1.70 
Open $0.21    52 Week Low $0.58 
Day High $0.21    P/E N/A 
Day Low $0.21    EPS $0.00 
Volume 26